These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 2600944

  • 1. Retrospective analysis of 376 irradiated patients with ankylosing spondylitis and nonirradiated controls.
    Calin A, Elswood J.
    J Rheumatol; 1989 Nov; 16(11):1443-5. PubMed ID: 2600944
    [Abstract] [Full Text] [Related]

  • 2. Self- and manual mobilization improves spine mobility in men with ankylosing spondylitis--a randomized study.
    Widberg K, Karimi H, Hafström I.
    Clin Rehabil; 2009 Jul; 23(7):599-608. PubMed ID: 19403551
    [Abstract] [Full Text] [Related]

  • 3. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.
    Zink A, Braun J, Listing J, Wollenhaupt J.
    J Rheumatol; 2000 Mar; 27(3):613-22. PubMed ID: 10743798
    [Abstract] [Full Text] [Related]

  • 4. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E, Conner-Spady B, Russell AS, Maksymowych WP.
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [Abstract] [Full Text] [Related]

  • 5. Measuring disability in ankylosing spondylitis: comparison of bath ankylosing spondylitis functional index with revised Leeds Disability Questionnaire.
    Eyres S, Tennant A, Kay L, Waxman R, Helliwell PS.
    J Rheumatol; 2002 May; 29(5):979-86. PubMed ID: 12022361
    [Abstract] [Full Text] [Related]

  • 6. Stability of the patient acceptable symptomatic state over time in outcome criteria in ankylosing spondylitis.
    Tubach F, Pham T, Skomsvoll JF, Mikkelsen K, Bjørneboe O, Ravaud P, Dougados M, Kvien TK.
    Arthritis Rheum; 2006 Dec 15; 55(6):960-3. PubMed ID: 17139643
    [Abstract] [Full Text] [Related]

  • 7. The long-term effect of posterolateral fusion in adult isthmic spondylolisthesis: a randomized controlled study.
    Ekman P, Möller H, Hedlund R.
    Spine J; 2005 Dec 15; 5(1):36-44. PubMed ID: 15653083
    [Abstract] [Full Text] [Related]

  • 8. Total hip arthroplasty in ankylosing spondylitis: outcome in 340 patients.
    Sweeney S, Gupta R, Taylor G, Calin A.
    J Rheumatol; 2001 Aug 15; 28(8):1862-6. PubMed ID: 11508591
    [Abstract] [Full Text] [Related]

  • 9. Predictors of the progression of functional disability in patients with ankylosing spondylitis.
    Ward MM.
    J Rheumatol; 2002 Jul 15; 29(7):1420-5. PubMed ID: 12136900
    [Abstract] [Full Text] [Related]

  • 10. Juvenile onset ankylosing spondylitis (JAS) has less severe spinal disease course than adult onset ankylosing spondylitis (AAS): clinical comparison between JAS and AAS in Korea.
    Baek HJ, Shin KC, Lee YJ, Kang SW, Lee EB, Yoo CD, Song YW.
    J Rheumatol; 2002 Aug 15; 29(8):1780-5. PubMed ID: 12180744
    [Abstract] [Full Text] [Related]

  • 11. Work status among patients with ankylosing spondylitis in Argentina.
    Marengo MF, Schneeberger EE, Citera G, Cocco JA.
    J Clin Rheumatol; 2008 Oct 15; 14(5):273-7. PubMed ID: 18679137
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary ankylosing spondylitis, psoriatic and enteropathic spondyloarthropathy: a controlled analysis.
    Edmunds L, Elswood J, Kennedy LG, Calin A.
    J Rheumatol; 1991 May 15; 18(5):696-8. PubMed ID: 1865416
    [Abstract] [Full Text] [Related]

  • 14. Is disease severity in ankylosing spondylitis genetically determined?
    Hamersma J, Cardon LR, Bradbury L, Brophy S, van der Horst-Bruinsma I, Calin A, Brown MA.
    Arthritis Rheum; 2001 Jun 15; 44(6):1396-400. PubMed ID: 11407700
    [Abstract] [Full Text] [Related]

  • 15. A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Maksymowych WP, Jhangri GS, Fitzgerald AA, LeClercq S, Chiu P, Yan A, Skeith KJ, Aaron SL, Homik J, Davis P, Sholter D, Russell AS.
    Arthritis Rheum; 2002 Mar 15; 46(3):766-73. PubMed ID: 11920413
    [Abstract] [Full Text] [Related]

  • 16. The effect of a home based exercise intervention package on outcome in ankylosing spondylitis: a randomized controlled trial.
    Sweeney S, Taylor G, Calin A.
    J Rheumatol; 2002 Apr 15; 29(4):763-6. PubMed ID: 11950019
    [Abstract] [Full Text] [Related]

  • 17. The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis.
    Barkham N, Kong KO, Tennant A, Fraser A, Hensor E, Keenan AM, Emery P.
    Rheumatology (Oxford); 2005 Oct 15; 44(10):1277-81. PubMed ID: 16105913
    [Abstract] [Full Text] [Related]

  • 18. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis.
    van Denderen JC, van der Paardt M, Nurmohamed MT, de Ryck YM, Dijkmans BA, van der Horst-Bruinsma IE.
    Ann Rheum Dis; 2005 Dec 15; 64(12):1761-4. PubMed ID: 15901634
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The Swedish version of the Bath ankylosing spondylitis disease activity index. Reliability and validity.
    Waldner A, Cronstedt H, Stenström CH.
    Scand J Rheumatol Suppl; 1999 Dec 15; 111():10-6. PubMed ID: 10503554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.